Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/11F181CF.svg?ark=w1%2F20260515%2F11F181CF)](https://nobleid.org/work/w1/20260515/11F181CF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors